What does ISANESTHESIA do?

ISANESTHESIA is a specialist medical practice in Villers-la-Ville. Private Limited, started on 11 April 2008, 2 establishments.

What is the address of ISANESTHESIA?

The registered office of ISANESTHESIA is located at Rue du Calvaire 11, 1495 Villers-la-Ville.

Is ISANESTHESIA still active?

Yes. According to the CBE (18 September 2026) ISANESTHESIA is active, legal situation “Normale toestand”, started on 11 April 2008.

Is ISANESTHESIA registered on Peppol?

Yes, ISANESTHESIA is registered on the Peppol network with ID 0208:0897213277.

What is the enterprise number of ISANESTHESIA?

The enterprise number of ISANESTHESIA is BE0897213277.

When was ISANESTHESIA founded?

ISANESTHESIA was founded on 11 April 2008.

Who are the directors of ISANESTHESIA?

According to the 2025 annual accounts, the directors of ISANESTHESIA are: Isabelle VANDENBERGHE.

Is ISANESTHESIA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 April 2008; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did ISANESTHESIA make in 2025?

ISANESTHESIA posted a profit after taxes of € 60,473 in financial year 2025.

What is the revenue of ISANESTHESIA?

As a small company, ISANESTHESIA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 101,177.

ISANESTHESIA (Private Limited) - Villers-la-Ville

Dossier ISANESTHESIA, printed on 18 September 2026 from databakkes.be/en/0897213277/isanesthesia. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ISANESTHESIA from Villers-la-Ville, company number BE0897213277, closed financial year 2025 with a result of € 60,473 after tax. For that financial year ISANESTHESIA recorded a gross margin of € 101,177 and equity of € 188,843. Compared with financial year 2024, the result moved from € 57,445 to € 60,473. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Healthy

€ 188,843

▼ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 60,473

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 87,717

▲ 97% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 81,209 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 29,255

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 15,748

▼ 39% vs 2024

€ 10,394 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 101

▼ 85% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 16,669

▲ 162% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 103,753 Gross margin 2022: € 103,753 First fiscal year in the series	€ 88,846 Gross margin 2023: € 88,846 ▼ 14% vs 2022 (€ 103,753) Unfavourable step	€ 96,637 Gross margin 2024: € 96,637 ▲ 9% vs 2023 (€ 88,846) Favourable step	€ 101,177 Gross margin 2025: € 101,177 ▲ 5% vs 2024 (€ 96,637) Favourable step	▲ 5%
Profit after taxes	€ 61,613 Profit after taxes 2022: € 61,613 First fiscal year in the series	€ 56,665 Profit after taxes 2023: € 56,665 ▼ 8% vs 2022 (€ 61,613) Unfavourable step	€ 57,445 Profit after taxes 2024: € 57,445 ▲ 1% vs 2023 (€ 56,665) Favourable step	€ 60,473 Profit after taxes 2025: € 60,473 ▲ 5% vs 2024 (€ 57,445) Favourable step	▲ 5%
Equity	€ 122,576 Equity 2022: € 122,576 First fiscal year in the series	€ 163,635 Equity 2023: € 163,635 ▲ 33% vs 2022 (€ 122,576) Favourable step	€ 209,579 Equity 2024: € 209,579 ▲ 28% vs 2023 (€ 163,635) Favourable step	€ 188,843 Equity 2025: € 188,843 ▼ 10% vs 2024 (€ 209,579) Unfavourable step	▼ 10%
Total debts	€ 46,107 Total debts 2022: € 46,107 First fiscal year in the series	€ 86,943 Total debts 2023: € 86,943 ▲ 89% vs 2022 (€ 46,107) Unfavourable step	€ 43,700 Total debts 2024: € 43,700 ▼ 50% vs 2023 (€ 86,943) Favourable step	€ 108,503 Total debts 2025: € 108,503 ▲ 148% vs 2024 (€ 43,700) Unfavourable step	▲ 148%
Cash	€ 48,720 Cash 2022: € 48,720 First fiscal year in the series	€ 55,965 Cash 2023: € 55,965 ▲ 15% vs 2022 (€ 48,720) Favourable step	€ 44,606 Cash 2024: € 44,606 ▼ 20% vs 2023 (€ 55,965) Unfavourable step	€ 87,717 Cash 2025: € 87,717 ▲ 97% vs 2024 (€ 44,606) Favourable step	▲ 97%
Land & buildings	€ 1,068 Land & buildings 2022: € 1,068 First fiscal year in the series	€ 712 Land & buildings 2023: € 712 ▼ 33% vs 2022 (€ 1,068) Unchanged	€ 356 Land & buildings 2024: € 356 ▼ 50% vs 2023 (€ 712) Unchanged	-
Retained profit	€ 110,176 Retained profit 2022: € 110,176 First fiscal year in the series	€ 149,375 Retained profit 2023: € 149,375 ▲ 36% vs 2022 (€ 110,176) Favourable step	€ 195,319 Retained profit 2024: € 195,319 ▲ 31% vs 2023 (€ 149,375) Favourable step	€ 174,583 Retained profit 2025: € 174,583 ▼ 11% vs 2024 (€ 195,319) Unfavourable step	▼ 11%
Dividend	€ 12,716 Dividend 2022: € 12,716 First fiscal year in the series	€ 15,606 Dividend 2023: € 15,606 ▲ 23% vs 2022 (€ 12,716) Unchanged	€ 11,502 Dividend 2024: € 11,502 ▼ 26% vs 2023 (€ 15,606) Unchanged	€ 81,209 Dividend 2025: € 81,209 ▲ € 69,707 vs 2024 (€ 11,502) Unchanged	▲ € 69,707
Bank debt	€ 4,704 Bank debt 2022: € 4,704 First fiscal year in the series	€ 35,340 Bank debt 2023: € 35,340 ▲ € 30,635 vs 2022 (€ 4,704) Unfavourable step	€ 25,738 Bank debt 2024: € 25,738 ▼ 27% vs 2023 (€ 35,340) Favourable step	€ 15,748 Bank debt 2025: € 15,748 ▼ 39% vs 2024 (€ 25,738) Favourable step	▼ 39%
Balance sheet total	€ 168,684 Balance sheet total 2022: € 168,684 First fiscal year in the series	€ 250,579 Balance sheet total 2023: € 250,579 ▲ 49% vs 2022 (€ 168,684) Unchanged	€ 253,279 Balance sheet total 2024: € 253,279 ▲ 1% vs 2023 (€ 250,579) Unchanged	€ 297,347 Balance sheet total 2025: € 297,347 ▲ 17% vs 2024 (€ 253,279) Unchanged	▲ 17%

Key figures of ISANESTHESIA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ISANESTHESIA?

What happened at ISANESTHESIA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 60,473 (▲ 5% vs 2024). Source: NBB ↗
Apr 11, 2008 New establishment in Braine-le-Château. KBO
Apr 11, 2008 New establishment in Villers-la-Ville. KBO
Apr 11, 2008 Start of the company according to the CBE. KBO

In short

From € 61,613 profit in 2022 to € 60,473 profit in 2025.

Paid € 101,494 in corporate taxes since 2022.

Best year ever: 2022, with € 61,613 profit.

Paid out € 121,033 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at ISANESTHESIA? We notify you, reason included.

Follow ISANESTHESIA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Isabelle VANDENBERGHE

ISANESTHESIA

Behind ISANESTHESIA is Isabelle VANDENBERGHE.

See the full network in the app

Directors

According to the 2025 annual accounts

Isabelle VANDENBERGHE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Calvaire 11

1495 Villers-la-Ville

2.186.564.003

Rue du Drabe 34

1440 Braine-le-Château

Active since 11 April 2008

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0897.213.277
VAT number: BE 0897.213.277
Registered office: Rue du Calvaire 11, 1495 Villers-la-Ville
Names & denominations: ISANESTHESIA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 11 April 2008
Peppol: Active · Active since 23 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗